ImmunoBiome

Microbiome-targeted therapeutics for intractable immune diseases

Headquarters
Pohang
Employees
1–10
Business Model
B2B
Last Round
Series BDec 2019
Rounds
2

About

ImmunoBiome Inc. is a South Korean biotech company located within the POSTECH (Pohang University of Science and Technology) campus, focused on developing microbiome-based therapeutics for intractable immune diseases including cancer and autoimmune conditions. The company leverages advanced immunology, bioinformatics, and microbiome-oriented basic research to discover and develop novel live biotherapeutic products. Its lead pipeline candidates IMB001 and IMB002 target oncology and inflammatory disease indications.

Summary

ImmunoBiome is a Biotech company based in Pohang, South Korea. Its most recent funding was a Series B round in Dec 2019. Investors include SBI Investment Korea, Union Ventures and AJU IB Investment.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundDec 2019

Sign up to see all 2 rounds

Series B through Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ImmunoBiome on Indexed.vc
<a href="https://indexed.vc/companies/immunobiome"><img src="https://indexed.vc/api/badge/company/immunobiome" alt="ImmunoBiome on Indexed.vc" width="260" height="76" /></a>